Is surgical intervention frequently required for medically managed macroprolactinomas? A study of spontaneous cerebrospinal fluid rhinorrhea

Surg Neurol. 2009 Nov;72(5):461-3; discussion 463. doi: 10.1016/j.surneu.2009.06.005. Epub 2009 Aug 7.

Abstract

Background: The frequency of spontaneous CSF rhinorrhea in macroprolactinoma patients is poorly documented and was previously thought to be a very rare occurrence.

Methods: Thirty patients with macroprolactinomas (>1.0 cm diameter) identified from the Swansea neuroendocrine database were studied retrospectively.

Results: At presentation, the median serum prolactin was 28,354 (range, 1844 to >6,000,000) mU/L; radiologically, 4 adenomas were invading the cavernous sinus, one the sphenoid sinus and 5 both the cavernous and sphenoid sinus. After commencement of medical therapy, 4 subjects developed CSF rhinorrhea requiring surgical correction; all 4 had tumors invading both the cavernous and sphenoid sinus and an initial serum prolactin more than 75,000 mU/L. One subject developed an acute psychosis, and a man who presented with delayed puberty committed a serious sexual offense.

Conclusions: Serious adverse effects are not uncommon in medically treated macroprolactinoma patients. Subjects with adenomas invading the sphenoid sinus have a high risk of developing CSF rhinorrhea that requires neurosurgical intervention.

MeSH terms

  • Adult
  • Biomarkers / analysis
  • Biomarkers / blood
  • Cavernous Sinus / diagnostic imaging
  • Cavernous Sinus / pathology
  • Cerebrospinal Fluid Rhinorrhea / etiology
  • Cerebrospinal Fluid Rhinorrhea / pathology*
  • Cerebrospinal Fluid Rhinorrhea / surgery*
  • Clinical Protocols
  • Craniotomy / methods
  • Craniotomy / standards
  • Disease Progression
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Nasal Cavity / pathology
  • Nasal Cavity / surgery
  • Neoplasm Invasiveness / pathology
  • Neoplasm Invasiveness / physiopathology
  • Neurosurgical Procedures / standards
  • Pituitary Gland / diagnostic imaging
  • Pituitary Gland / pathology
  • Pituitary Gland / surgery
  • Pituitary Neoplasms / drug therapy
  • Pituitary Neoplasms / pathology*
  • Pituitary Neoplasms / surgery*
  • Prolactin / analysis
  • Prolactin / blood
  • Prolactin / metabolism
  • Prolactinoma / drug therapy
  • Prolactinoma / pathology*
  • Prolactinoma / surgery*
  • Retrospective Studies
  • Risk Assessment
  • Sphenoid Bone / diagnostic imaging
  • Sphenoid Bone / pathology
  • Sphenoid Bone / surgery
  • Sphenoid Sinus / diagnostic imaging
  • Sphenoid Sinus / pathology
  • Sphenoid Sinus / surgery
  • Tomography, X-Ray Computed

Substances

  • Biomarkers
  • Prolactin